These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2108313)

  • 41. American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccines: update.
    Pediatrics; 1989 Aug; 84(2):386-7. PubMed ID: 2748273
    [No Abstract]   [Full Text] [Related]  

  • 42. Safety and efficacy of Haemophilus influenzae type b polysaccharide vaccine.
    Granoff DM; Osterholm MT
    Pediatrics; 1987 Oct; 80(4):590-2. PubMed ID: 3498928
    [No Abstract]   [Full Text] [Related]  

  • 43. Haemophilus b conjugate vaccines.
    Vella PP; Ellis RW
    Biotechnology; 1992; 20():1-22. PubMed ID: 1600377
    [No Abstract]   [Full Text] [Related]  

  • 44. Acute inflammatory demyelinating polyradiculoneuropathy (Guillain-Barré syndrome) after immunization with Haemophilus influenzae type b conjugate vaccine.
    D'Cruz OF; Shapiro ED; Spiegelman KN; Leicher CR; Breningstall GN; Khatri BO; Dobyns WB
    J Pediatr; 1989 Nov; 115(5 Pt 1):743-6. PubMed ID: 2809907
    [No Abstract]   [Full Text] [Related]  

  • 45. Haemophilus influenzae infections and whooping cough.
    Moxon ER; Rappuoli R
    Lancet; 1990 Jun; 335(8701):1324-9. PubMed ID: 1971388
    [No Abstract]   [Full Text] [Related]  

  • 46. Add another dose of Haemophilus influenzae vaccine.
    Lawson BE
    MCN Am J Matern Child Nurs; 1992; 17(2):69, 108. PubMed ID: 1463483
    [No Abstract]   [Full Text] [Related]  

  • 47. Additional dose urged for some receiving Haemophilus influenzae vaccine in early '90s.
    Marwick C
    JAMA; 1992 Dec; 268(23):3287. PubMed ID: 1453513
    [No Abstract]   [Full Text] [Related]  

  • 48. H influenzae vaccines gain favor.
    Marwick C
    JAMA; 1990 Sep; 264(11):1375. PubMed ID: 2391729
    [No Abstract]   [Full Text] [Related]  

  • 49. Interchangeability of conjugated Haemophilus influenzae type b vaccines during primary immunisation of infants.
    Goldblatt D; Fairley CK; Cartwright K; Miller E
    BMJ; 1996 Mar; 312(7034):817-8. PubMed ID: 8608290
    [No Abstract]   [Full Text] [Related]  

  • 50. Decline of Haemophilus disease in Cleveland.
    Schreiber JR; Boxerbaum B; Morrissey AB
    Pediatr Infect Dis J; 1992 Sep; 11(9):779-80. PubMed ID: 1448329
    [No Abstract]   [Full Text] [Related]  

  • 51. Timing of the booster dose with Haemophilus polyribosylribitol phosphate conjugated with Neisseria outer-membrane protein.
    Calandra GB; Mendelman PM
    J Pediatr; 1992 Jul; 121(1):172. PubMed ID: 1625087
    [No Abstract]   [Full Text] [Related]  

  • 52. Work continues on extending protection against Haemophilus influenzae to very young infants.
    Marwick C
    JAMA; 1990 Jul; 264(2):164. PubMed ID: 2192094
    [No Abstract]   [Full Text] [Related]  

  • 53. CGVD workshop: should Haemophilus influenzae type B conjugate vaccines be introduced into the EPI?
    Keusch GT
    Lancet; 1992 Mar; 339(8796):802-3. PubMed ID: 1347819
    [No Abstract]   [Full Text] [Related]  

  • 54. The effects of stopper drying on moisture levels of Haemophilus influenzae conjugate vaccine.
    Earle JP; Bennett PS; Larson KA; Shaw R
    Dev Biol Stand; 1992; 74():203-10. PubMed ID: 1592170
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A high-molecular-weight outer membrane protein that is a potential target for protective immunity to type b and untypeable Haemophilus influenzae.
    Thomas WR; Flack FS; Callow MG; Chua KY
    J Infect Dis; 1992 Jun; 165 Suppl 1():S75-6. PubMed ID: 1588185
    [No Abstract]   [Full Text] [Related]  

  • 56. [Haemophilus b vaccines].
    Olivier C
    Presse Med; 1992 May; 21(20):923-5. PubMed ID: 1386439
    [No Abstract]   [Full Text] [Related]  

  • 57. [Anti-Haemophilus influenzae vaccination].
    Gomirato G; Nigro G
    Minerva Pediatr; 1992; 44(1-2):57-8. PubMed ID: 1552881
    [No Abstract]   [Full Text] [Related]  

  • 58. Vaccine development: progression from target antigen to product.
    Ellis RW
    Adv Exp Med Biol; 1992; 327():263-71. PubMed ID: 1295345
    [No Abstract]   [Full Text] [Related]  

  • 59. Protection induced against acute bronchitis--the use of human and rat models to determine mechanisms of action of oral immunization with Haemophilus influenzae.
    Clancy RL; Wallace FJ; Cripps AW; Pang GT
    Curr Top Microbiol Immunol; 1989; 146():181-5. PubMed ID: 2786462
    [No Abstract]   [Full Text] [Related]  

  • 60. Prevention of postsplenectomy sepsis.
    Mayon-White RT
    Lancet; 1993 Jan; 341(8839):248-9. PubMed ID: 8093537
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.